(*) JP Approval Date: 2021. 12.24
(*) UK Approval Date: 2021. 11.04
(*) USA EUA Date: 2021. 12.23
>Oral
Company
Generic Name: Molnupiravir
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2021. 11.02
PR Web-Site (UK)
PR Web-Site (USA)
RN: RiboNucleoside
RTM